Nathalie Berruet, Pharm D, MBA
About Nathalie Berruet, Pharm D, MBA
Nathalie Berruet, Pharm D, MBA, is the Director and Biologics Drug Product Planning Lead at Bristol-Myers Squibb in New York City, with over 20 years of experience in the pharmaceutical industry.
Title
Nathalie Berruet serves as the Director, Biologics Drug Product Planning Lead at Bristol-Myers Squibb. Since February 2020, she has managed planning activities for biologics drug products within the organization.
Company
Nathalie Berruet is currently employed at Bristol-Myers Squibb, a leading global biopharmaceutical company. She works in the Région de New York City, États-Unis, where she oversees biologics drug product planning.
Education and Expertise
Nathalie Berruet holds multiple degrees, including a Pharm.D. from Université Paris Sud (Paris XI) where she studied Biologics and Pharmacotechnology from 2003 to 2005. Additionally, she achieved a Master of Advanced Studies in Biopharmacy - Formulation and Pharmatechnology from the same university in 2001. She also holds an MBA, enhancing her managerial and strategic skills in the pharmaceutical industry. Her foundational education includes a high school diploma with a specialization in Physics and Chemistry from Lycée Jean Monnet, received in 2001.
Background
Nathalie Berruet has over 20 years of experience in the pharmaceutical industry. Her career has been focused on biologics drug product planning, supported by her advanced studies in biopharmacy and pharmacotechnology. Her expertise spans the formulation and development of biologic drugs, consistent with her academic and professional background.
Specialization in Biologics Drug Product Planning
Nathalie Berruet specializes in biologics drug product planning, a role that involves orchestrating the development and lifecycle management of biologic therapies. Her experience in this domain is underpinned by her comprehensive education in pharmacotechnology and biopharmacy, coupled with her strategic acumen derived from her MBA.